Ekso Bionics Holdings, Inc.
General ticker "EKSO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $30.4M (TTM average)
Ekso Bionics Holdings, Inc. follows the US Stock Market performance with the rate: 54.5%.
Estimated limits based on current volatility of 8.6%: low 18.49$, high 21.98$
Factors to consider:
- Total employees count: 66 (-8.3%) as of 2024
- US accounted for 54.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Failed business combo, Failure to secure reimbursement, Supply chain disruptions, Regulatory and compliance, Recurring operating losses
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.58$, 9.30$]
- 2025-12-31 to 2026-12-31 estimated range: [1.59$, 5.72$]
Financial Metrics affecting the EKSO estimates:
- Negative: with PPE of -16.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -79.77 <= 0.30
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of -0.30 > -0.65
- Positive: Interest expense per share per price, % of 2.18 <= 3.33
- Positive: -9.07 < Industry operating profit margin (median), % of -7.92
Short-term EKSO quotes
Long-term EKSO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $12.91MM | $18.28MM | $17.93MM |
| Operating Expenses | $28.47MM | $33.39MM | $28.39MM |
| Operating Income | $-15.56MM | $-15.11MM | $-10.46MM |
| Non-Operating Income | $0.48MM | $-0.09MM | $-0.87MM |
| Interest Expense | $0.16MM | $0.30MM | $0.27MM |
| R&D Expense | $3.63MM | $5.03MM | $3.87MM |
| Income(Loss) | $-15.08MM | $-15.20MM | $-11.33MM |
| Net Income(Loss)* | $-15.08MM | $-15.20MM | $-11.33MM |
| Stockholders Equity | $25.44MM | $12.61MM | $12.71MM |
| Assets | $40.90MM | $28.92MM | $26.65MM |
| Operating Cash Flow | $-14.69MM | $-12.05MM | $-9.85MM |
| Capital expenditure | $0.19MM | $0.16MM | $0.04MM |
| Investing Cash Flow | $-5.17MM | $-0.16MM | $-0.04MM |
| Financing Cash Flow | $0.00MM | $0.35MM | $7.77MM |
| Earnings Per Share** | $-17.45 | $-16.44 | $-8.43 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.